Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
December 20, 2011
Patent Application Number
12180045
Date Filed
July 25, 2008
Patent Citations Received
0
Patent Primary Examiner
Patent abstract
The present invention relates to peptides, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-helper cell peptide epitopes, alone or in combination with other tumor-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumor immune responses. The present invention relates to novel peptide sequences and their variants derived from HLA class I and class II molecules of human tumor cells which can be used in vaccine compositions for eliciting anti-tumor immune responses.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.